期刊
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
卷 201, 期 6, 页码 547-552出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2009.09.034
关键词
H1N1; influenza vaccine; pregnancy; safety
资金
- National Institutes of Health (NIH)
- Centers for Disease Control and Prevention (CDC)
- Emory Global Health Institute, Merck and Co., Inc. (West Point, PA)
- Bill and Melinda Gates Foundation, NIH
- Wyeth Vaccines
- Berna, Intercel, Merck (North Wales, PA), Novartis, CDC
- Bill and Melinda Gates Foundation, CDC, Merck (North Wales, PA)
- Emory Global Health Institute
The Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recommends routine influenza vaccination for all women who are or will be pregnant during the influenza season. During seasonal influenza epidemics, during previous pandemics, and with the current influenza A (H1N1) pandemic, pregnancy places otherwise healthy women at increased risk for serious complications from influenza, including death. Inactivated influenza vaccine can be safely and effectively administered during any trimester of pregnancy. No study to date has demonstrated an increased risk of either maternal complications or adverse fetal outcomes associated with inactivated influenza vaccination. Moreover, no scientific evidence exists that thimerosal-containing vaccines are a cause of adverse events among children born to women who received influenza vaccine during pregnancy. In this article, we review the evidentiary basis for the recommendation of vaccination of all women who will be pregnant during the influenza season and safety data of influenza vaccination during pregnancy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据